Skip to main content

Patient Stories

Stay up to date: Okuvision’s newsfeed features the latest posts for healthcare professionals, those affected, and anyone interested in TES therapy with OkuStim® for retinitis pigmentosa. Whether research, care, everyday life, or personal stories—this is where we bring together medical content and insights into living with RP.

Patient Story – Anja Renner

Paratriathlete Anja Renner openly shares her life with RP and her experiences with OkuStim® therapy – honest, relatable, encouraging.

Everything but Flying

Former pilot Reinhard stabilizes his condition with TES – with routine and confidence.

Maintaining quality of life

Ines has relied on TES for years – active in her studies, sport, and everyday life.

Seize Opportunities

Living with RP for decades, using TES since 2019: Haap relies on structure, support, and optimism. He reports noticeable changes in his daily life.

A Fighter by Experience

Caterina has been using TES for three years and speaks openly about challenges, routine, and impact.

Okuvision – Preserving Vision. Protecting Quality of Life.

Okuvision develops innovative therapeutic solutions for people living with retinitis pigmentosa (RP), an inherited retinal disease that can lead to progressive vision loss. With OkuStim®, we offer an evidence-based therapy designed to slow disease progression and help patients preserve their vision for longer. Together with patients, ophthalmologists, and research partners, we are committed to advancing innovative treatment options and improving quality of life.

ContactPartners & Sources of Supply

The OkuStim® therapy was developed for patients with degenerative retinal diseases such as retinitis pigmentosa. It may help slow the progression of the disease. At the core of the therapy is the OkuStim® System, which enables you to stimulate your retina independently at home using low-level electrical currents.

Learn more about Clinical Evidence

Okuvision products are not for sale in the USA.